AAAAAA
Results:
1-7
|
Results: 7
Authors:
DALFONSO S
BORELLI I
DALLOMO A
BOLOGNESI E
PARTANEN J
LEVO A
POCIOT F
FAN L
JUJI T
HAMMOND M
TOSI R
RICHIARDI PM
Citation: S. Dalfonso et al., THE NATURAL-HISTORY OF AN HLA HAPLOTYPE AND ITS RECOMBINANTS, Immunogenetics (New York), 48(1), 1998, pp. 8-15
Authors:
LEVO A
PARTANEN J
Citation: A. Levo et J. Partanen, NOVEL NONSENSE MUTATION (W302X) IN THE STEROID 21-HYDROXYLASE GENE OFA FINNISH PATIENT WITH THE SALT-WASTING FORM OF CONGENITAL ADRENAL-HYPERPLASIA, Human mutation, 9(4), 1997, pp. 363-365
Authors:
LAJIC S
LEVO A
NIKOSHKOV A
LUNDBERG Y
PARTANEN J
WEDELL A
Citation: S. Lajic et al., A CLUSTER OF MISSENSE MUTATIONS AT ARG356 OF HUMAN STEROID 21-HYDROXYLASE MAY IMPAIR REDOX PARTNER INTERACTION, Human genetics, 99(6), 1997, pp. 704-709
Authors:
LEVO A
PARTANEN J
Citation: A. Levo et J. Partanen, MUTATION-HAPLOTYPE ANALYSIS OF STEROID 21-HYDROXYLASE (CYP21) DEFICIENCY IN FINLAND - IMPLICATIONS FOR THE POPULATION HISTORY OF DEFECTIVE ALLELES, Human genetics, 99(4), 1997, pp. 488-497
Authors:
JAASKELAINEN J
LEVO A
VOUTILAINEN R
PARTANEN J
Citation: J. Jaaskelainen et al., POPULATION-WIDE EVALUATION OF DISEASE MANIFESTATION IN RELATION TO MOLECULAR GENOTYPE IN STEROID 21-HYDROXYLASE (CYP21) DEFICIENCY - GOOD CORRELATION IN A WELL-DEFINED POPULATION, The Journal of clinical endocrinology and metabolism, 82(10), 1997, pp. 3293-3297
Authors:
LEVO A
WESTMAN P
PARTANEN J
Citation: A. Levo et al., AN APPROACH TO MAPPING HAPLOTYPE-SPECIFIC RECOMBINATION SITES IN HUMAN MHC CLASS-III, Immunogenetics, 43(3), 1996, pp. 136-140
Authors:
NARKO K
LEVO A
PARTANEN J
Citation: K. Narko et al., A RARE NEUTRAL POLYMORPHISM IN 21-HYDROXYLASE GENES AS HLA HAPLOTYPE MARKER - EVIDENCE FOR STRONG FOUNDER EFFECT IN THE FINNISH POPULATION, Human immunology, 43(1), 1995, pp. 66-71
Risultati:
1-7
|